The therapeutic landscape of HIV-1 via genome editing

Current treatment for HIV-1 largely relies on chemotherapy through the administration of antiretroviral drugs. While the search for anti-HIV-1 vaccine remain elusive, the use of highly active antiretroviral therapies (HAART) have been far-reaching and has changed HIV-1 into a manageable chronic infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwarteng, Alexander, Ahuno, Samuel Terkper, Kwakye-Nuako, Godwin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513397/
https://www.ncbi.nlm.nih.gov/pubmed/28705213
http://dx.doi.org/10.1186/s12981-017-0157-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513397/
https://www.ncbi.nlm.nih.gov/pubmed/28705213
http://dx.doi.org/10.1186/s12981-017-0157-8

Ejemplares similares